Holen Sie sich die Stockscreener-App
39.98
2.77%
-1.14
Handel nachbörslich:
39.20
-0.78
-1.95%
Schlusskurs vom Vortag:
$41.12
Offen:
$40.84
24-Stunden-Volumen:
1.62M
Relative Volume:
1.27
Marktkapitalisierung:
$3.80B
Einnahmen:
$47.30M
Nettoeinkommen (Verlust:
$-225.97M
KGV:
-17.01
EPS:
-2.35
Netto-Cashflow:
$-188.86M
1W Leistung:
+3.15%
1M Leistung:
+17.45%
6M Leistung:
-14.44%
1J Leistung:
+333.62%
1-Tages-Spanne:
$39.66
$41.32
1-Wochen-Bereich:
$39.02
$43.97
52-Wochen-Spanne:
$6.76
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Firmenname
Scholar Rock Holding Corp
Sektor
Branche
Telefon
857-259-3860
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie SRRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
39.98 | 3.68B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-10-07 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Strong Buy |
| 2023-10-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-07-12 | Eingeleitet | Truist | Buy |
| 2022-03-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-06 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-12 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
What analysts say about Scholar Rock Holding Corporation stockMarket-beating performance - jammulinksnews.com
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Sells 72,236 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) - MarketBeat
Arizona State Retirement System Increases Stock Position in Scholar Rock Holding Corporation (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corporation (NASDAQ:SRRK) Director Jeffrey S. Flier Sells 11,136 Shares - MarketBeat
Scholar Rock Earnings Preview: SMA Drug Developer Sets Q2 Results Date, Key Updates Expected - Stock Titan
Scholar Rock to Host Conference Call to Discuss Second Quarter 2025 Financial Results and Provide Business Update on August 6, 2025 - FinancialContent
Cantor Fitzgerald Forecasts Scholar Rock FY2025 Earnings - Defense World
Scholar Rock (NASDAQ:SRRK) Now Covered by Cantor Fitzgerald - MarketBeat
Scholar Rock (NASDAQ:SRRK) Research Coverage Started at Cantor Fitzgerald - Defense World
M&T Bank Corp Sells 489 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corporation Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com
What drives Scholar Rock Holding Corporation stock priceSuperior returns - jammulinksnews.com
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Will CVR Energy Inc. stock benefit from AI tech trendsFree Access to Community with 300% Return - Newser
Use AI to optimize your outbound sales efforts by targeting the right prospectsFree Premium Stock Market Reports - Newser
Scholar Rock Holding (SRRK) Gains Analyst Support with New Cover - GuruFocus
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives $42.67 Average PT from Brokerages - MarketBeat
What makes Scholar Rock Holding Corporation stock price move sharplyFree AI-Powered Stock Predictions - Newser
How Scholar Rock Holding Corporation stock performs during market volatilityCapital Preservation Investment Ideas - Newser
Why Scholar Rock Holding Corporation stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser
How Alarum Technologies Ltd. Depositary Receipt stock performs during market volatilitySecure Your Capital Strategy - Newser
Scholar Rock (NASDAQ:SRRK) Trading Up 6.5%What's Next? - MarketBeat
Scholar Rock CSO Mo Qatanani sells $828,898 in shares By Investing.com - Investing.com Nigeria
High Growth Tech Stocks To Watch In US July 2025 - Yahoo Finance
Scholar Rock CSO Mo Qatanani sells $828,898 in shares - Investing.com Australia
Insider Sell: Mo Qatanani Sells 24,066 Shares of Scholar Rock Ho - GuruFocus
Scholar Rock Q1 2025 slides: apitegromab advances toward FDA approval with priority review - Investing.com Nigeria
Scholar Rock Holding Corporation(NasdaqGS:SRRK) dropped from Russell 3000E Value Index - MarketScreener
Scholar Rock (NASDAQ:SRRK) Trading Up 5.2%Here's What Happened - MarketBeat
Truist reiterates buy rating on Scholar Rock stock amid SMA therapy potential - Investing.com Nigeria
Is Scholar Rock Holding Corp. overvalued or undervalued? - MarketsMojo
Scholar Rock CEO on its drug that could preserve muscle in weight-loss drug users - CNBC
Syncona restructures biotech fund; Lilly’s $1B Verve bet; FDA’s two-track future — a BioCentury podcast - biocentury.com
Scholar Rock's Breakthrough SMA Drug Shows Positive Phase 3 Results, FDA Fast-Tracks Review - Stock Titan
Scholar Rock (NASDAQ:SRRK) Trading Down 5.7% – Time to Sell? - Defense World
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
SG Americas Securities LLC Increases Position in Scholar Rock Holding Corporation (NASDAQ:SRRK) - Defense World
Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial - Yahoo Finance
Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush - MarketBeat
Why Scholar Rock Shares Are Soaring Today - The Globe and Mail
Scholar Rock (NASDAQ:SRRK) Shares Gap UpWhat's Next? - MarketBeat
Transcript : Scholar Rock Holding CorporationSpecial Call - MarketScreener
Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results - Yahoo Finance
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study - Benzinga
Scholar Rock stock soars after drug shows promise in preserving lean mass during weight loss - Investing.com Australia
Finanzdaten der Scholar Rock Holding Corp-Aktie (SRRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):